61478-26-0 Usage
Description
BOC-HYP-OL, also known as tert-Butyl 4-(hydroxymethyl)pyrrolidine-1-carboxylate, is a chemical compound that serves as a versatile building block in the synthesis of various pharmaceutical compounds. It is characterized by its reactivity and ability to form derivatives, making it a valuable component in the development of new drugs and therapeutic agents.
Uses
Used in Pharmaceutical Industry:
BOC-HYP-OL is used as a reactant for the preparation of 4-purinylpyrrolidine nucleosides, which are important in the development of new drugs targeting various diseases and conditions. Its unique structure allows for the creation of novel compounds with potential therapeutic applications.
Used in Kinase Inhibitor Development:
BOC-HYP-OL is utilized as a key component in the synthesis of kinase inhibitors, which are crucial in the treatment of various cancers and other diseases. By targeting specific kinases, these inhibitors can help regulate cellular processes and prevent the uncontrolled growth of cancer cells.
Used in Antibacterial Agent Synthesis:
In the field of antibacterial drug development, BOC-HYP-OL serves as a valuable reactant for the creation of new agents that can combat bacterial infections. Its incorporation into the synthesis process allows for the development of more effective and targeted treatments against various bacterial strains.
Check Digit Verification of cas no
The CAS Registry Mumber 61478-26-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,4,7 and 8 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 61478-26:
(7*6)+(6*1)+(5*4)+(4*7)+(3*8)+(2*2)+(1*6)=130
130 % 10 = 0
So 61478-26-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H19NO4/c1-10(2,3)15-9(14)11-5-8(13)4-7(11)6-12/h7-8,12-13H,4-6H2,1-3H3/t7-,8+/m1/s1
61478-26-0Relevant articles and documents
OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION
-
, (2015/02/02)
The present invention relates to ligand conjugates of oligonucleotides (e.g., iRNA agents) and methods for their preparation. The ligands are derived primarily from monosaccharides These conjugates are useful for the in vivo delivery of oligonucleotides.
A practical synthesis of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane
Beinat, Corinne,Banister, Samuel D.,McErlean, Christopher S.P.,Kassiou, Michael
, p. 5345 - 5347 (2013/09/12)
The rigid piperazine homologue 2,5-diazabicyclo[2.2.1]heptane (DBH) finds extensive application in medicinal chemistry and pharmaceutical research, but access to this scaffold is non-trivial. This letter details a concise synthetic sequence that gives ready access to DBH on gram scale. The route features a Staudinger reduction of an azide to facilitate a transannular cyclisation.
Synthesis of (1S,4S)-2-Thia-5-azabicycloheptane
Jordis, Ulrich,Sauter, Fritz,Siddiqi, Suhaib M.
, p. 294 - 296 (2007/10/02)
Starting from trans-4-hydroxy-L-proline, (1S,4S)-2-thia-5-azabicycloheptane (1) has been synthesised via the key intermediate N-(t-butoxycarbonyl)-trans-4-hydroxy-L-prolinol ditosylate (7).